Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.90
Ask: 17.98
Change: -0.50 (-2.86%)
Spread: 1.08 (6.391%)
Open: 17.20
High: 17.20
Low: 17.00
Prev. Close: 17.50
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

30 Jul 2018 07:00

RNS Number : 0813W
Nanoco Group PLC
30 July 2018
 

30 July 2018

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Directorate Changes

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, today announces that, as part of a structured reorganisation of the Company's executive team following Keith Wiggins resignation as Chief Operating Officer in June, Nanoco will combine its Chief Financial Officer and Chief Operating Officer positions into one unified role.

 

The Board is pleased to announce that Brian Tenner has been appointed to this new combined role, effective from 20 August 2018. Brian is currently Chief Financial Officer of NCC Group plc ("NCC"), a leading pure play cyber security advisory business. On the 20 June 2018 it was announced that Brian would leave NCC in August 2018. Previously he was Group Finance Director and a member of the Board at Renold Plc (2010-2016), Scapa Group Plc (2007-2010) and BNFL Plc - British Nuclear Group (2003-2007).

 

As a result of the reorganisation, David Blain will stand down from his position as Chief Financial Officer on the 20 August 2018. David will remain with Nanoco until 15 October 2018 to facilitate an orderly handover of his duties.

 

There is no further information to be disclosed relating to Brian under paragraph 9.6.13 of the UK Listing Authority Listing Rules.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"On behalf of the whole team, I would like to thank David for the very significant contribution he has made to Nanoco as our Chief Financial Officer over the past three years. He has been a key part of the team as we have driven our commercialisation strategy and maintained robust financing and tight control over costs. We wish him well for all his future endeavours.

 

"I would like to welcome Brian to the team in this newly created role. His extensive experience will be invaluable to our Executive Team and the Board as Nanoco continues to gain commercial momentum."

 

- Ends -

 

 

For further information, please contact:

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

 

Chris Richards, Non-Executive Chairman

 

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

 

 

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

 

The information contained within this announcement constitutes inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAZVLFLVDFBBBE
Date   Source Headline
15th May 20134:45 pmRNSHolding(s) in Company
14th May 20135:52 pmRNSHolding(s) in Company
9th May 201312:30 pmRNSRelocation of CEO to the US and Director Dealings
2nd May 20137:00 amRNSSigns Follow-on Agreement
29th Apr 20137:00 amRNSBoard Changes
24th Apr 20137:00 amRNSHolding(s) in Company
11th Apr 20134:46 pmRNSHolding(s) in Company
11th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20132:00 pmRNSAppointment of Joint Broker
27th Mar 20132:20 pmRNSHolding (s) in Company
18th Mar 20137:00 amRNSInterim Results
15th Feb 20132:08 pmRNSHolding(s) in Company
14th Feb 20131:00 pmRNSHolding(s) in Company
12th Feb 20139:49 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSAppointment of Key Business Development Executives
29th Jan 20134:18 pmRNSHolding(s) in Company
28th Jan 20136:06 pmRNSHolding(s) in Company
24th Jan 20135:51 pmRNSHolding(s) in Company
23rd Jan 20137:00 amRNSLicensing Agreement with Dow Chemical
21st Jan 20137:00 amRNSNotification of Interim Results
11th Jan 20138:59 amRNSHolding(s) in Company
10th Jan 20131:19 pmRNSHolding(s) in Company
20th Dec 20127:00 amRNSSigns further agreement with Tokyo Electron
14th Dec 201210:25 amRNSResult of AGM
14th Dec 20127:00 amRNSAGM Statement
12th Dec 20123:37 pmRNSBlock Listing Application
4th Dec 20127:00 amRNSExercise of Options
12th Nov 20127:00 amRNSPosting of Annual Report & Accounts
23rd Oct 20127:00 amRNSGrant of Options
19th Oct 201212:43 pmRNSDirectors' Dealings and Exercise of Options
15th Oct 20127:00 amRNSPreliminary Results
5th Oct 20127:00 amRNSFollow-on Lighting Agreement
5th Sep 20127:00 amRNSNotification of Preliminary Results
20th Aug 20127:00 amRNSWins Government Grants
1st Aug 20127:00 amRNSTotal Voting Rights
31st Jul 20127:00 amRNSSigns Joint Development Agreement
27th Jul 20127:00 amRNSExercise of Options
25th Jun 20127:00 amRNSChange of Adviser
9th May 20127:00 amRNSAchieves US$2m Milestone
2nd Apr 20122:15 pmRNSTotal Voting Rights
28th Mar 20127:00 amRNSExercise of Options
26th Mar 20127:00 amRNSInterim Results
14th Feb 20127:00 amRNSSigns Joint Development Agreement
10th Feb 20128:56 amRNSHolding(s) in Company
7th Feb 20128:58 amRNSHolding(s) in Company
7th Feb 20128:55 amRNSHolding(s) in Company
31st Jan 20127:00 amRNSAchieves US$1m Milestone
25th Jan 20124:40 pmRNSSecond Price Monitoring Extn
25th Jan 20124:35 pmRNSPrice Monitoring Extension
20th Jan 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.